Concepedia

Zydus Pharmaceuticals (United States)

ZP

19

Publications

384

Citations

1

Authors

Pennington

United States

Zydus Pharmaceuticals (United States) is a company institution in Pennington, United States known for atherosclerosis, metabolic syndrome, and hepatology.

HomepageROR

Top concepts

Publications

19

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral NLRP3 Inflammasome Inhibitor ZYIL1: First‐in‐Human Phase 1 Studies (Single Ascending Dose and Multiple Ascending Dose)

Kevinkumar Kansagra, Taufik Momin, Hardik B. Patel et al. · Clinical Pharmacology in Drug Development · 2022 · 62 citations · Full text

Saroglitazar, a Dual PPAR α/γ Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled Analysis

Mohammad Shadab Siddiqui, Farheen Sheikh, Shiv Kumar Sarin et al. · Clinical Gastroenterology and Hepatology · 2023 · 35 citations

, , +13

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZY‐IL1 in Three Patients with Cryopyrin‐Associated Periodic Syndromes

Pravin Hissaria, Kevinkumar Kansagra, Hardik B. Patel et al. · Clinical Pharmacology in Drug Development · 2023 · 24 citations · Full text

Saroglitazar improves nonalcoholic fatty liver disease and metabolic health in liver transplant recipients

Mohammad Shadab Siddiqui, Farheen Shaikh, Mikael Forsgren et al. · Liver Transplantation · 2023 · 17 citations

Rows per page

1–4 of 19

Authors

1

PublicationsCitationsH-Index
AB
Ajay Barot

Zydus Pharmaceuticals (United States)

1

62

1

Rows per page

1–1 of 1